Dr. Andreas Jeromin Leading Panel on Identifying Biological Markers of Posttraumatic Stress Disorder at ISTSS 36th Annual Meeting, November 4-14November 4, 2020Read more
Our Chief Scientific Officer Dr. Andreas Jeromin is leading a panel discussion at the ISTSS 37th Annual Meeting, titled “Identifying Biological Markers of Posttraumatic Stress Disorder (PTSD): Recent Findings and Efforts Across Modalities to Enhance Rigor and Robustness”.
- November 2, 2020Read more
Null Hypothesis is a collaborative initiative dedicated to publishing well-performed replication and negative studies — or studies where the outcomes do not confirm expected results or working hypotheses — via dedicated journal space.
Join CVB and other researchers and clinicians at the virtual 10th Annual Traumatic Brain Injury ConferenceOctober 27, 2020Read more
Our Chief Scientific Officer, Dr. Andreas Jeromin, is Chairing the conference on November 2-4, 2020 and will be joined by the CVB leadership team. Dr. Jeromin will be discussing recommendations from the Brain Trauma Blueprint 2019 State of the Science Summit.
- October 23, 2020Read more
We are excited to virtually attend and exhibit at the 2020 CNS Summit, October 29 – November 1, 2020.
This annual event convenes innovators across industry, academia, media, non-profit organizations, and others to enable networking, discussion, and collaboration in clinical development.
Dr. Andreas Jeromin featured as a speaker at the 2020 Virtual World Congress of Psychiatric Genetics, October 16-22October 23, 2020Read more
Our Chief Scientific Officer Dr. Andreas Jeromin presented a symposium titled “Understanding the Biology of Posttraumatic Stress Disorder: Genome-Wide Association Studies, Phenotyping Strategies, Multivariate Gene-Environment Interactions, and Translational Research” at the 2020 Virtual World Congress of Psychiatric Genetics.